Clinical Trial Update: RA-2 13-cis Retinoic Acid (Isotretinoin) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for RA-2 13-cis retinoic acid (isotretinoin) involving male infertility conditions; study has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Klinefelter Syndrome
• Male Infertility
• Y-chromosome Microdeletions

Drugs mentioned

• RA-2 13-cis retinoic acid (isotretinoin) (isotretinoin)

Snippet

Sponsor: University of Washington | Conditions: Male Infertility, Klinefelter's Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2021-07-30